Pharma & Healthcare
Global NAD+ Booster Capsule Market Outlook, In‑Depth Analysis & Forecast to 2031
- Oct 21, 25
- ID: 554019
- Pages: 155
- Figures: 151
- Views: 8
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global NAD+ Booster Capsule market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
GeneHarbor
Chromadex
Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
Herbalmax
EffePharm
Kingdomway
NOMON Co., Ltd. (Teijin)
CELFULL
Bontac
Genex Formulas
EZZ
Maac10 Formulas
Elysium Health
Segment by Type
Content ＜98%
Content ≥98%
Segment by Application
Health Care Products
Beauty Products
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the NAD+ Booster Capsule study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global NAD+ Booster Capsule market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
GeneHarbor
Chromadex
Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
Herbalmax
EffePharm
Kingdomway
NOMON Co., Ltd. (Teijin)
CELFULL
Bontac
Genex Formulas
EZZ
Maac10 Formulas
Elysium Health
Segment by Type
Content ＜98%
Content ≥98%
Segment by Application
Health Care Products
Beauty Products
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the NAD+ Booster Capsule study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to NAD+ Booster Capsule: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global NAD+ Booster Capsule Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Content ＜98%
1.2.3 Content ≥98%
1.3 Market Segmentation by Application
1.3.1 Global NAD+ Booster Capsule Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Health Care Products
1.3.3 Beauty Products
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global NAD+ Booster Capsule Revenue Estimates and Forecasts 2020-2031
2.2 Global NAD+ Booster Capsule Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global NAD+ Booster Capsule Sales Estimates and Forecasts 2020-2031
2.4 Global NAD+ Booster Capsule Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global NAD+ Booster Capsule Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global NAD+ Booster Capsule Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Content ＜98% Market Size by Manufacturers
3.5.2 Content ≥98% Market Size by Manufacturers
3.6 Global NAD+ Booster Capsule Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global NAD+ Booster Capsule Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global NAD+ Booster Capsule Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global NAD+ Booster Capsule Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global NAD+ Booster Capsule Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America NAD+ Booster Capsule Sales and Revenue by Type (2020-2031)
6.4 North America NAD+ Booster Capsule Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America NAD+ Booster Capsule Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe NAD+ Booster Capsule Sales and Revenue by Type (2020-2031)
7.4 Europe NAD+ Booster Capsule Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe NAD+ Booster Capsule Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific NAD+ Booster Capsule Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific NAD+ Booster Capsule Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific NAD+ Booster Capsule Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America NAD+ Booster Capsule Sales and Revenue by Type (2020-2031)
9.4 Central and South America NAD+ Booster Capsule Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America NAD+ Booster Capsule Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa NAD+ Booster Capsule Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa NAD+ Booster Capsule Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa NAD+ Booster Capsule Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 GeneHarbor
11.1.1 GeneHarbor Corporation Information
11.1.2 GeneHarbor Business Overview
11.1.3 GeneHarbor NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.1.4 GeneHarbor NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 GeneHarbor NAD+ Booster Capsule Sales by Product in 2024
11.1.6 GeneHarbor NAD+ Booster Capsule Sales by Application in 2024
11.1.7 GeneHarbor NAD+ Booster Capsule Sales by Geographic Area in 2024
11.1.8 GeneHarbor NAD+ Booster Capsule SWOT Analysis
11.1.9 GeneHarbor Recent Developments
11.2 Chromadex
11.2.1 Chromadex Corporation Information
11.2.2 Chromadex Business Overview
11.2.3 Chromadex NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.2.4 Chromadex NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Chromadex NAD+ Booster Capsule Sales by Product in 2024
11.2.6 Chromadex NAD+ Booster Capsule Sales by Application in 2024
11.2.7 Chromadex NAD+ Booster Capsule Sales by Geographic Area in 2024
11.2.8 Chromadex NAD+ Booster Capsule SWOT Analysis
11.2.9 Chromadex Recent Developments
11.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
11.3.1 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Corporation Information
11.3.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Business Overview
11.3.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.3.4 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule Sales by Product in 2024
11.3.6 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule Sales by Application in 2024
11.3.7 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule Sales by Geographic Area in 2024
11.3.8 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule SWOT Analysis
11.3.9 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Developments
11.4 Herbalmax
11.4.1 Herbalmax Corporation Information
11.4.2 Herbalmax Business Overview
11.4.3 Herbalmax NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.4.4 Herbalmax NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Herbalmax NAD+ Booster Capsule Sales by Product in 2024
11.4.6 Herbalmax NAD+ Booster Capsule Sales by Application in 2024
11.4.7 Herbalmax NAD+ Booster Capsule Sales by Geographic Area in 2024
11.4.8 Herbalmax NAD+ Booster Capsule SWOT Analysis
11.4.9 Herbalmax Recent Developments
11.5 EffePharm
11.5.1 EffePharm Corporation Information
11.5.2 EffePharm Business Overview
11.5.3 EffePharm NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.5.4 EffePharm NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 EffePharm NAD+ Booster Capsule Sales by Product in 2024
11.5.6 EffePharm NAD+ Booster Capsule Sales by Application in 2024
11.5.7 EffePharm NAD+ Booster Capsule Sales by Geographic Area in 2024
11.5.8 EffePharm NAD+ Booster Capsule SWOT Analysis
11.5.9 EffePharm Recent Developments
11.6 Kingdomway
11.6.1 Kingdomway Corporation Information
11.6.2 Kingdomway Business Overview
11.6.3 Kingdomway NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.6.4 Kingdomway NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Kingdomway Recent Developments
11.7 NOMON Co., Ltd. (Teijin)
11.7.1 NOMON Co., Ltd. (Teijin) Corporation Information
11.7.2 NOMON Co., Ltd. (Teijin) Business Overview
11.7.3 NOMON Co., Ltd. (Teijin) NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.7.4 NOMON Co., Ltd. (Teijin) NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 NOMON Co., Ltd. (Teijin) Recent Developments
11.8 CELFULL
11.8.1 CELFULL Corporation Information
11.8.2 CELFULL Business Overview
11.8.3 CELFULL NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.8.4 CELFULL NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 CELFULL Recent Developments
11.9 Bontac
11.9.1 Bontac Corporation Information
11.9.2 Bontac Business Overview
11.9.3 Bontac NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.9.4 Bontac NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Bontac Recent Developments
11.10 Genex Formulas
11.10.1 Genex Formulas Corporation Information
11.10.2 Genex Formulas Business Overview
11.10.3 Genex Formulas NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.10.4 Genex Formulas NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Genex Formulas Recent Developments
11.11 EZZ
11.11.1 EZZ Corporation Information
11.11.2 EZZ Business Overview
11.11.3 EZZ NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.11.4 EZZ NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 EZZ Recent Developments
11.12 Maac10 Formulas
11.12.1 Maac10 Formulas Corporation Information
11.12.2 Maac10 Formulas Business Overview
11.12.3 Maac10 Formulas NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.12.4 Maac10 Formulas NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Maac10 Formulas Recent Developments
11.13 Elysium Health
11.13.1 Elysium Health Corporation Information
11.13.2 Elysium Health Business Overview
11.13.3 Elysium Health NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.13.4 Elysium Health NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Elysium Health Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 NAD+ Booster Capsule Industry Chain
12.2 NAD+ Booster Capsule Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 NAD+ Booster Capsule Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 NAD+ Booster Capsule Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 NAD+ Booster Capsule Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global NAD+ Booster Capsule Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to NAD+ Booster Capsule: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global NAD+ Booster Capsule Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Content ＜98%
1.2.3 Content ≥98%
1.3 Market Segmentation by Application
1.3.1 Global NAD+ Booster Capsule Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Health Care Products
1.3.3 Beauty Products
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global NAD+ Booster Capsule Revenue Estimates and Forecasts 2020-2031
2.2 Global NAD+ Booster Capsule Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global NAD+ Booster Capsule Sales Estimates and Forecasts 2020-2031
2.4 Global NAD+ Booster Capsule Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global NAD+ Booster Capsule Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global NAD+ Booster Capsule Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Content ＜98% Market Size by Manufacturers
3.5.2 Content ≥98% Market Size by Manufacturers
3.6 Global NAD+ Booster Capsule Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global NAD+ Booster Capsule Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global NAD+ Booster Capsule Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global NAD+ Booster Capsule Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global NAD+ Booster Capsule Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America NAD+ Booster Capsule Sales and Revenue by Type (2020-2031)
6.4 North America NAD+ Booster Capsule Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America NAD+ Booster Capsule Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe NAD+ Booster Capsule Sales and Revenue by Type (2020-2031)
7.4 Europe NAD+ Booster Capsule Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe NAD+ Booster Capsule Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific NAD+ Booster Capsule Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific NAD+ Booster Capsule Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific NAD+ Booster Capsule Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America NAD+ Booster Capsule Sales and Revenue by Type (2020-2031)
9.4 Central and South America NAD+ Booster Capsule Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America NAD+ Booster Capsule Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa NAD+ Booster Capsule Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa NAD+ Booster Capsule Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa NAD+ Booster Capsule Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 GeneHarbor
11.1.1 GeneHarbor Corporation Information
11.1.2 GeneHarbor Business Overview
11.1.3 GeneHarbor NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.1.4 GeneHarbor NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 GeneHarbor NAD+ Booster Capsule Sales by Product in 2024
11.1.6 GeneHarbor NAD+ Booster Capsule Sales by Application in 2024
11.1.7 GeneHarbor NAD+ Booster Capsule Sales by Geographic Area in 2024
11.1.8 GeneHarbor NAD+ Booster Capsule SWOT Analysis
11.1.9 GeneHarbor Recent Developments
11.2 Chromadex
11.2.1 Chromadex Corporation Information
11.2.2 Chromadex Business Overview
11.2.3 Chromadex NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.2.4 Chromadex NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Chromadex NAD+ Booster Capsule Sales by Product in 2024
11.2.6 Chromadex NAD+ Booster Capsule Sales by Application in 2024
11.2.7 Chromadex NAD+ Booster Capsule Sales by Geographic Area in 2024
11.2.8 Chromadex NAD+ Booster Capsule SWOT Analysis
11.2.9 Chromadex Recent Developments
11.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
11.3.1 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Corporation Information
11.3.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Business Overview
11.3.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.3.4 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule Sales by Product in 2024
11.3.6 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule Sales by Application in 2024
11.3.7 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule Sales by Geographic Area in 2024
11.3.8 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule SWOT Analysis
11.3.9 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Developments
11.4 Herbalmax
11.4.1 Herbalmax Corporation Information
11.4.2 Herbalmax Business Overview
11.4.3 Herbalmax NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.4.4 Herbalmax NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Herbalmax NAD+ Booster Capsule Sales by Product in 2024
11.4.6 Herbalmax NAD+ Booster Capsule Sales by Application in 2024
11.4.7 Herbalmax NAD+ Booster Capsule Sales by Geographic Area in 2024
11.4.8 Herbalmax NAD+ Booster Capsule SWOT Analysis
11.4.9 Herbalmax Recent Developments
11.5 EffePharm
11.5.1 EffePharm Corporation Information
11.5.2 EffePharm Business Overview
11.5.3 EffePharm NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.5.4 EffePharm NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 EffePharm NAD+ Booster Capsule Sales by Product in 2024
11.5.6 EffePharm NAD+ Booster Capsule Sales by Application in 2024
11.5.7 EffePharm NAD+ Booster Capsule Sales by Geographic Area in 2024
11.5.8 EffePharm NAD+ Booster Capsule SWOT Analysis
11.5.9 EffePharm Recent Developments
11.6 Kingdomway
11.6.1 Kingdomway Corporation Information
11.6.2 Kingdomway Business Overview
11.6.3 Kingdomway NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.6.4 Kingdomway NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Kingdomway Recent Developments
11.7 NOMON Co., Ltd. (Teijin)
11.7.1 NOMON Co., Ltd. (Teijin) Corporation Information
11.7.2 NOMON Co., Ltd. (Teijin) Business Overview
11.7.3 NOMON Co., Ltd. (Teijin) NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.7.4 NOMON Co., Ltd. (Teijin) NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 NOMON Co., Ltd. (Teijin) Recent Developments
11.8 CELFULL
11.8.1 CELFULL Corporation Information
11.8.2 CELFULL Business Overview
11.8.3 CELFULL NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.8.4 CELFULL NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 CELFULL Recent Developments
11.9 Bontac
11.9.1 Bontac Corporation Information
11.9.2 Bontac Business Overview
11.9.3 Bontac NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.9.4 Bontac NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Bontac Recent Developments
11.10 Genex Formulas
11.10.1 Genex Formulas Corporation Information
11.10.2 Genex Formulas Business Overview
11.10.3 Genex Formulas NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.10.4 Genex Formulas NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Genex Formulas Recent Developments
11.11 EZZ
11.11.1 EZZ Corporation Information
11.11.2 EZZ Business Overview
11.11.3 EZZ NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.11.4 EZZ NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 EZZ Recent Developments
11.12 Maac10 Formulas
11.12.1 Maac10 Formulas Corporation Information
11.12.2 Maac10 Formulas Business Overview
11.12.3 Maac10 Formulas NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.12.4 Maac10 Formulas NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Maac10 Formulas Recent Developments
11.13 Elysium Health
11.13.1 Elysium Health Corporation Information
11.13.2 Elysium Health Business Overview
11.13.3 Elysium Health NAD+ Booster Capsule Product Models, Descriptions and Specifications
11.13.4 Elysium Health NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Elysium Health Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 NAD+ Booster Capsule Industry Chain
12.2 NAD+ Booster Capsule Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 NAD+ Booster Capsule Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 NAD+ Booster Capsule Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 NAD+ Booster Capsule Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global NAD+ Booster Capsule Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global NAD+ Booster Capsule Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global NAD+ Booster Capsule Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global NAD+ Booster Capsule Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global NAD+ Booster Capsule Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global NAD+ Booster Capsule Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global NAD+ Booster Capsule Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global NAD+ Booster Capsule Sales by Region (2020-2025) & (K Units)
Table 8. Global NAD+ Booster Capsule Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global NAD+ Booster Capsule Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global NAD+ Booster Capsule Sales Share by Manufacturers (2020-2025)
Table 12. Global NAD+ Booster Capsule Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global NAD+ Booster Capsule Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global NAD+ Booster Capsule by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NAD+ Booster Capsule as of 2024)
Table 16. Global NAD+ Booster Capsule Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global NAD+ Booster Capsule Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers NAD+ Booster Capsule Manufacturing Base and Headquarters
Table 19. Global NAD+ Booster Capsule Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global NAD+ Booster Capsule Sales by Type (2020-2025) & (K Units)
Table 23. Global NAD+ Booster Capsule Sales by Type (2026-2031) & (K Units)
Table 24. Global NAD+ Booster Capsule Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global NAD+ Booster Capsule Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global NAD+ Booster Capsule ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global NAD+ Booster Capsule Sales by Application (2020-2025) & (K Units)
Table 29. Global NAD+ Booster Capsule Sales by Application (2026-2031) & (K Units)
Table 30. NAD+ Booster Capsule High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global NAD+ Booster Capsule Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global NAD+ Booster Capsule Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global NAD+ Booster Capsule ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America NAD+ Booster Capsule Growth Accelerators and Market Barriers
Table 37. North America NAD+ Booster Capsule Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America NAD+ Booster Capsule Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe NAD+ Booster Capsule Growth Accelerators and Market Barriers
Table 40. Europe NAD+ Booster Capsule Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe NAD+ Booster Capsule Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific NAD+ Booster Capsule Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific NAD+ Booster Capsule Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific NAD+ Booster Capsule Growth Accelerators and Market Barriers
Table 45. Southeast Asia NAD+ Booster Capsule Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America NAD+ Booster Capsule Investment Opportunities and Key Challenges
Table 47. Central and South America NAD+ Booster Capsule Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa NAD+ Booster Capsule Investment Opportunities and Key Challenges
Table 49. Middle East and Africa NAD+ Booster Capsule Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. GeneHarbor Corporation Information
Table 51. GeneHarbor Description and Major Businesses
Table 52. GeneHarbor Product Models, Descriptions and Specifications
Table 53. GeneHarbor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. GeneHarbor Sales Value Proportion by Product in 2024
Table 55. GeneHarbor Sales Value Proportion by Application in 2024
Table 56. GeneHarbor Sales Value Proportion by Geographic Area in 2024
Table 57. GeneHarbor NAD+ Booster Capsule SWOT Analysis
Table 58. GeneHarbor Recent Developments
Table 59. Chromadex Corporation Information
Table 60. Chromadex Description and Major Businesses
Table 61. Chromadex Product Models, Descriptions and Specifications
Table 62. Chromadex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Chromadex Sales Value Proportion by Product in 2024
Table 64. Chromadex Sales Value Proportion by Application in 2024
Table 65. Chromadex Sales Value Proportion by Geographic Area in 2024
Table 66. Chromadex NAD+ Booster Capsule SWOT Analysis
Table 67. Chromadex Recent Developments
Table 68. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Corporation Information
Table 69. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Description and Major Businesses
Table 70. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Product Models, Descriptions and Specifications
Table 71. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Sales Value Proportion by Product in 2024
Table 73. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Sales Value Proportion by Application in 2024
Table 74. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Sales Value Proportion by Geographic Area in 2024
Table 75. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule SWOT Analysis
Table 76. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Developments
Table 77. Herbalmax Corporation Information
Table 78. Herbalmax Description and Major Businesses
Table 79. Herbalmax Product Models, Descriptions and Specifications
Table 80. Herbalmax Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Herbalmax Sales Value Proportion by Product in 2024
Table 82. Herbalmax Sales Value Proportion by Application in 2024
Table 83. Herbalmax Sales Value Proportion by Geographic Area in 2024
Table 84. Herbalmax NAD+ Booster Capsule SWOT Analysis
Table 85. Herbalmax Recent Developments
Table 86. EffePharm Corporation Information
Table 87. EffePharm Description and Major Businesses
Table 88. EffePharm Product Models, Descriptions and Specifications
Table 89. EffePharm Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. EffePharm Sales Value Proportion by Product in 2024
Table 91. EffePharm Sales Value Proportion by Application in 2024
Table 92. EffePharm Sales Value Proportion by Geographic Area in 2024
Table 93. EffePharm NAD+ Booster Capsule SWOT Analysis
Table 94. EffePharm Recent Developments
Table 95. Kingdomway Corporation Information
Table 96. Kingdomway Description and Major Businesses
Table 97. Kingdomway Product Models, Descriptions and Specifications
Table 98. Kingdomway Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Kingdomway Recent Developments
Table 100. NOMON Co., Ltd. (Teijin) Corporation Information
Table 101. NOMON Co., Ltd. (Teijin) Description and Major Businesses
Table 102. NOMON Co., Ltd. (Teijin) Product Models, Descriptions and Specifications
Table 103. NOMON Co., Ltd. (Teijin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. NOMON Co., Ltd. (Teijin) Recent Developments
Table 105. CELFULL Corporation Information
Table 106. CELFULL Description and Major Businesses
Table 107. CELFULL Product Models, Descriptions and Specifications
Table 108. CELFULL Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. CELFULL Recent Developments
Table 110. Bontac Corporation Information
Table 111. Bontac Description and Major Businesses
Table 112. Bontac Product Models, Descriptions and Specifications
Table 113. Bontac Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Bontac Recent Developments
Table 115. Genex Formulas Corporation Information
Table 116. Genex Formulas Description and Major Businesses
Table 117. Genex Formulas Product Models, Descriptions and Specifications
Table 118. Genex Formulas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Genex Formulas Recent Developments
Table 120. EZZ Corporation Information
Table 121. EZZ Description and Major Businesses
Table 122. EZZ Product Models, Descriptions and Specifications
Table 123. EZZ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. EZZ Recent Developments
Table 125. Maac10 Formulas Corporation Information
Table 126. Maac10 Formulas Description and Major Businesses
Table 127. Maac10 Formulas Product Models, Descriptions and Specifications
Table 128. Maac10 Formulas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Maac10 Formulas Recent Developments
Table 130. Elysium Health Corporation Information
Table 131. Elysium Health Description and Major Businesses
Table 132. Elysium Health Product Models, Descriptions and Specifications
Table 133. Elysium Health Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Elysium Health Recent Developments
Table 135. Key Raw Materials Distribution
Table 136. Raw Materials Key Suppliers
Table 137. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 138. Milestones in Production Technology Evolution
Table 139. Distributors List
Table 140. Market Trends and Market Evolution
Table 141. Market Drivers and Opportunities
Table 142. Market Challenges, Risks, and Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. NAD+ Booster Capsule Product Picture
Figure 2. Global NAD+ Booster Capsule Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Content ＜98% Product Picture
Figure 4. Content ≥98% Product Picture
Figure 5. Global NAD+ Booster Capsule Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Health Care Products
Figure 7. Beauty Products
Figure 8. Others
Figure 9. NAD+ Booster Capsule Report Years Considered
Figure 10. Global NAD+ Booster Capsule Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 12. Global NAD+ Booster Capsule Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global NAD+ Booster Capsule Revenue Market Share by Region (2020-2031)
Figure 14. Global NAD+ Booster Capsule Sales (2020-2031) & (K Units)
Figure 15. Global NAD+ Booster Capsule Sales (CAGR) by Region (2020-2031) (K Units)
Figure 16. Global NAD+ Booster Capsule Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers NAD+ Booster Capsule Sales Volume Market Share in 2024
Figure 18. Global NAD+ Booster Capsule Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Content ＜98% Revenue Market Share by Manufacturer in 2024
Figure 21. Content ≥98% Revenue Market Share by Manufacturer in 2024
Figure 22. Global NAD+ Booster Capsule Sales Market Share by Type (2020-2031)
Figure 23. Global NAD+ Booster Capsule Revenue Market Share by Type (2020-2031)
Figure 24. Global NAD+ Booster Capsule Sales Market Share by Application (2020-2031)
Figure 25. Global NAD+ Booster Capsule Revenue Market Share by Application (2020-2031)
Figure 26. North America NAD+ Booster Capsule Sales YoY (2020-2031) & (K Units)
Figure 27. North America NAD+ Booster Capsule Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers NAD+ Booster Capsule Sales Revenue (US$ Million) in 2024
Figure 29. North America NAD+ Booster Capsule Sales Volume (K Units) by Type (2020- 2031)
Figure 30. North America NAD+ Booster Capsule Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America NAD+ Booster Capsule Sales Volume (K Units) by Application (2020-2031)
Figure 32. North America NAD+ Booster Capsule Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 34. Canada NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 36. Europe NAD+ Booster Capsule Sales YoY (2020-2031) & (K Units)
Figure 37. Europe NAD+ Booster Capsule Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers NAD+ Booster Capsule Sales Revenue (US$ Million) in 2024
Figure 39. Europe NAD+ Booster Capsule Sales Volume (K Units) by Type (2020-2031)
Figure 40. Europe NAD+ Booster Capsule Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe NAD+ Booster Capsule Sales Volume (K Units) by Application (2020-2031)
Figure 42. Europe NAD+ Booster Capsule Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 44. France NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 46. Italy NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 47. Russia NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific NAD+ Booster Capsule Sales YoY (2020-2031) & (K Units)
Figure 49. Asia-Pacific NAD+ Booster Capsule Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers NAD+ Booster Capsule Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific NAD+ Booster Capsule Sales Volume (K Units) by Type (2020- 2031)
Figure 52. Asia-Pacific NAD+ Booster Capsule Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific NAD+ Booster Capsule Sales Volume (K Units) by Application (2020-2031)
Figure 54. Asia-Pacific NAD+ Booster Capsule Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 56. Japan NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 59. India NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America NAD+ Booster Capsule Sales YoY (2020-2031) & (K Units)
Figure 61. Central and South America NAD+ Booster Capsule Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers NAD+ Booster Capsule Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America NAD+ Booster Capsule Sales Volume (K Units) by Type (2021-2031)
Figure 64. Central and South America NAD+ Booster Capsule Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America NAD+ Booster Capsule Sales Volume (K Units) by Application (2020-2031)
Figure 66. Central and South America NAD+ Booster Capsule Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil NAD+ Booster Capsule Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina NAD+ Booster Capsule Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa NAD+ Booster Capsule Sales YoY (2020-2031) & (K Units)
Figure 70. Middle East and Africa NAD+ Booster Capsule Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers NAD+ Booster Capsule Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa NAD+ Booster Capsule Sales Volume (K Units) by Type (2021-2031)
Figure 73. South America NAD+ Booster Capsule Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa NAD+ Booster Capsule Sales Volume (K Units) by Application (2020-2031)
Figure 75. Middle East and Africa NAD+ Booster Capsule Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries NAD+ Booster Capsule Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey NAD+ Booster Capsule Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt NAD+ Booster Capsule Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa NAD+ Booster Capsule Revenue (2020-2025) & (US$ Million)
Figure 80. NAD+ Booster Capsule Industry Chain Mapping
Figure 81. Regional NAD+ Booster Capsule Manufacturing Base Distribution (%)
Figure 82. Global NAD+ Booster Capsule Production Market Share by Region (2020-2031)
Figure 83. NAD+ Booster Capsule Production Process
Figure 84. Regional NAD+ Booster Capsule Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
Table 1. Global NAD+ Booster Capsule Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global NAD+ Booster Capsule Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global NAD+ Booster Capsule Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global NAD+ Booster Capsule Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global NAD+ Booster Capsule Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global NAD+ Booster Capsule Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global NAD+ Booster Capsule Sales by Region (2020-2025) & (K Units)
Table 8. Global NAD+ Booster Capsule Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global NAD+ Booster Capsule Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global NAD+ Booster Capsule Sales Share by Manufacturers (2020-2025)
Table 12. Global NAD+ Booster Capsule Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global NAD+ Booster Capsule Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global NAD+ Booster Capsule by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NAD+ Booster Capsule as of 2024)
Table 16. Global NAD+ Booster Capsule Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global NAD+ Booster Capsule Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers NAD+ Booster Capsule Manufacturing Base and Headquarters
Table 19. Global NAD+ Booster Capsule Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global NAD+ Booster Capsule Sales by Type (2020-2025) & (K Units)
Table 23. Global NAD+ Booster Capsule Sales by Type (2026-2031) & (K Units)
Table 24. Global NAD+ Booster Capsule Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global NAD+ Booster Capsule Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global NAD+ Booster Capsule ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global NAD+ Booster Capsule Sales by Application (2020-2025) & (K Units)
Table 29. Global NAD+ Booster Capsule Sales by Application (2026-2031) & (K Units)
Table 30. NAD+ Booster Capsule High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global NAD+ Booster Capsule Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global NAD+ Booster Capsule Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global NAD+ Booster Capsule ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America NAD+ Booster Capsule Growth Accelerators and Market Barriers
Table 37. North America NAD+ Booster Capsule Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America NAD+ Booster Capsule Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe NAD+ Booster Capsule Growth Accelerators and Market Barriers
Table 40. Europe NAD+ Booster Capsule Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe NAD+ Booster Capsule Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific NAD+ Booster Capsule Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific NAD+ Booster Capsule Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific NAD+ Booster Capsule Growth Accelerators and Market Barriers
Table 45. Southeast Asia NAD+ Booster Capsule Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America NAD+ Booster Capsule Investment Opportunities and Key Challenges
Table 47. Central and South America NAD+ Booster Capsule Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa NAD+ Booster Capsule Investment Opportunities and Key Challenges
Table 49. Middle East and Africa NAD+ Booster Capsule Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. GeneHarbor Corporation Information
Table 51. GeneHarbor Description and Major Businesses
Table 52. GeneHarbor Product Models, Descriptions and Specifications
Table 53. GeneHarbor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. GeneHarbor Sales Value Proportion by Product in 2024
Table 55. GeneHarbor Sales Value Proportion by Application in 2024
Table 56. GeneHarbor Sales Value Proportion by Geographic Area in 2024
Table 57. GeneHarbor NAD+ Booster Capsule SWOT Analysis
Table 58. GeneHarbor Recent Developments
Table 59. Chromadex Corporation Information
Table 60. Chromadex Description and Major Businesses
Table 61. Chromadex Product Models, Descriptions and Specifications
Table 62. Chromadex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Chromadex Sales Value Proportion by Product in 2024
Table 64. Chromadex Sales Value Proportion by Application in 2024
Table 65. Chromadex Sales Value Proportion by Geographic Area in 2024
Table 66. Chromadex NAD+ Booster Capsule SWOT Analysis
Table 67. Chromadex Recent Developments
Table 68. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Corporation Information
Table 69. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Description and Major Businesses
Table 70. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Product Models, Descriptions and Specifications
Table 71. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Sales Value Proportion by Product in 2024
Table 73. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Sales Value Proportion by Application in 2024
Table 74. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Sales Value Proportion by Geographic Area in 2024
Table 75. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule SWOT Analysis
Table 76. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Developments
Table 77. Herbalmax Corporation Information
Table 78. Herbalmax Description and Major Businesses
Table 79. Herbalmax Product Models, Descriptions and Specifications
Table 80. Herbalmax Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Herbalmax Sales Value Proportion by Product in 2024
Table 82. Herbalmax Sales Value Proportion by Application in 2024
Table 83. Herbalmax Sales Value Proportion by Geographic Area in 2024
Table 84. Herbalmax NAD+ Booster Capsule SWOT Analysis
Table 85. Herbalmax Recent Developments
Table 86. EffePharm Corporation Information
Table 87. EffePharm Description and Major Businesses
Table 88. EffePharm Product Models, Descriptions and Specifications
Table 89. EffePharm Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. EffePharm Sales Value Proportion by Product in 2024
Table 91. EffePharm Sales Value Proportion by Application in 2024
Table 92. EffePharm Sales Value Proportion by Geographic Area in 2024
Table 93. EffePharm NAD+ Booster Capsule SWOT Analysis
Table 94. EffePharm Recent Developments
Table 95. Kingdomway Corporation Information
Table 96. Kingdomway Description and Major Businesses
Table 97. Kingdomway Product Models, Descriptions and Specifications
Table 98. Kingdomway Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Kingdomway Recent Developments
Table 100. NOMON Co., Ltd. (Teijin) Corporation Information
Table 101. NOMON Co., Ltd. (Teijin) Description and Major Businesses
Table 102. NOMON Co., Ltd. (Teijin) Product Models, Descriptions and Specifications
Table 103. NOMON Co., Ltd. (Teijin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. NOMON Co., Ltd. (Teijin) Recent Developments
Table 105. CELFULL Corporation Information
Table 106. CELFULL Description and Major Businesses
Table 107. CELFULL Product Models, Descriptions and Specifications
Table 108. CELFULL Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. CELFULL Recent Developments
Table 110. Bontac Corporation Information
Table 111. Bontac Description and Major Businesses
Table 112. Bontac Product Models, Descriptions and Specifications
Table 113. Bontac Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Bontac Recent Developments
Table 115. Genex Formulas Corporation Information
Table 116. Genex Formulas Description and Major Businesses
Table 117. Genex Formulas Product Models, Descriptions and Specifications
Table 118. Genex Formulas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Genex Formulas Recent Developments
Table 120. EZZ Corporation Information
Table 121. EZZ Description and Major Businesses
Table 122. EZZ Product Models, Descriptions and Specifications
Table 123. EZZ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. EZZ Recent Developments
Table 125. Maac10 Formulas Corporation Information
Table 126. Maac10 Formulas Description and Major Businesses
Table 127. Maac10 Formulas Product Models, Descriptions and Specifications
Table 128. Maac10 Formulas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Maac10 Formulas Recent Developments
Table 130. Elysium Health Corporation Information
Table 131. Elysium Health Description and Major Businesses
Table 132. Elysium Health Product Models, Descriptions and Specifications
Table 133. Elysium Health Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Elysium Health Recent Developments
Table 135. Key Raw Materials Distribution
Table 136. Raw Materials Key Suppliers
Table 137. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 138. Milestones in Production Technology Evolution
Table 139. Distributors List
Table 140. Market Trends and Market Evolution
Table 141. Market Drivers and Opportunities
Table 142. Market Challenges, Risks, and Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. NAD+ Booster Capsule Product Picture
Figure 2. Global NAD+ Booster Capsule Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Content ＜98% Product Picture
Figure 4. Content ≥98% Product Picture
Figure 5. Global NAD+ Booster Capsule Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Health Care Products
Figure 7. Beauty Products
Figure 8. Others
Figure 9. NAD+ Booster Capsule Report Years Considered
Figure 10. Global NAD+ Booster Capsule Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 12. Global NAD+ Booster Capsule Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global NAD+ Booster Capsule Revenue Market Share by Region (2020-2031)
Figure 14. Global NAD+ Booster Capsule Sales (2020-2031) & (K Units)
Figure 15. Global NAD+ Booster Capsule Sales (CAGR) by Region (2020-2031) (K Units)
Figure 16. Global NAD+ Booster Capsule Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers NAD+ Booster Capsule Sales Volume Market Share in 2024
Figure 18. Global NAD+ Booster Capsule Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Content ＜98% Revenue Market Share by Manufacturer in 2024
Figure 21. Content ≥98% Revenue Market Share by Manufacturer in 2024
Figure 22. Global NAD+ Booster Capsule Sales Market Share by Type (2020-2031)
Figure 23. Global NAD+ Booster Capsule Revenue Market Share by Type (2020-2031)
Figure 24. Global NAD+ Booster Capsule Sales Market Share by Application (2020-2031)
Figure 25. Global NAD+ Booster Capsule Revenue Market Share by Application (2020-2031)
Figure 26. North America NAD+ Booster Capsule Sales YoY (2020-2031) & (K Units)
Figure 27. North America NAD+ Booster Capsule Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers NAD+ Booster Capsule Sales Revenue (US$ Million) in 2024
Figure 29. North America NAD+ Booster Capsule Sales Volume (K Units) by Type (2020- 2031)
Figure 30. North America NAD+ Booster Capsule Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America NAD+ Booster Capsule Sales Volume (K Units) by Application (2020-2031)
Figure 32. North America NAD+ Booster Capsule Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 34. Canada NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 36. Europe NAD+ Booster Capsule Sales YoY (2020-2031) & (K Units)
Figure 37. Europe NAD+ Booster Capsule Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers NAD+ Booster Capsule Sales Revenue (US$ Million) in 2024
Figure 39. Europe NAD+ Booster Capsule Sales Volume (K Units) by Type (2020-2031)
Figure 40. Europe NAD+ Booster Capsule Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe NAD+ Booster Capsule Sales Volume (K Units) by Application (2020-2031)
Figure 42. Europe NAD+ Booster Capsule Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 44. France NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 46. Italy NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 47. Russia NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific NAD+ Booster Capsule Sales YoY (2020-2031) & (K Units)
Figure 49. Asia-Pacific NAD+ Booster Capsule Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers NAD+ Booster Capsule Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific NAD+ Booster Capsule Sales Volume (K Units) by Type (2020- 2031)
Figure 52. Asia-Pacific NAD+ Booster Capsule Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific NAD+ Booster Capsule Sales Volume (K Units) by Application (2020-2031)
Figure 54. Asia-Pacific NAD+ Booster Capsule Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 56. Japan NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 59. India NAD+ Booster Capsule Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America NAD+ Booster Capsule Sales YoY (2020-2031) & (K Units)
Figure 61. Central and South America NAD+ Booster Capsule Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers NAD+ Booster Capsule Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America NAD+ Booster Capsule Sales Volume (K Units) by Type (2021-2031)
Figure 64. Central and South America NAD+ Booster Capsule Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America NAD+ Booster Capsule Sales Volume (K Units) by Application (2020-2031)
Figure 66. Central and South America NAD+ Booster Capsule Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil NAD+ Booster Capsule Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina NAD+ Booster Capsule Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa NAD+ Booster Capsule Sales YoY (2020-2031) & (K Units)
Figure 70. Middle East and Africa NAD+ Booster Capsule Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers NAD+ Booster Capsule Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa NAD+ Booster Capsule Sales Volume (K Units) by Type (2021-2031)
Figure 73. South America NAD+ Booster Capsule Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa NAD+ Booster Capsule Sales Volume (K Units) by Application (2020-2031)
Figure 75. Middle East and Africa NAD+ Booster Capsule Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries NAD+ Booster Capsule Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey NAD+ Booster Capsule Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt NAD+ Booster Capsule Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa NAD+ Booster Capsule Revenue (2020-2025) & (US$ Million)
Figure 80. NAD+ Booster Capsule Industry Chain Mapping
Figure 81. Regional NAD+ Booster Capsule Manufacturing Base Distribution (%)
Figure 82. Global NAD+ Booster Capsule Production Market Share by Region (2020-2031)
Figure 83. NAD+ Booster Capsule Production Process
Figure 84. Regional NAD+ Booster Capsule Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232